Socioeconomic status as a predictor of melanoma survival in a series of 1083 cases from Brazil: Just a marker of health services accessibility?

Melanoma Research

Volumn 23, Issue 3, 2013, Pages 199-205

  Quintella Mendes, Gelcio L ^a,b   Koifman, Sergio ^b  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

developing country; educational level; melanoma; socioeconomic status; survival

Indexed keywords

ADULT; ARTICLE; BRAZIL; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; DEVELOPING COUNTRY; EDUCATIONAL STATUS; ETHNICITY; FEMALE; HEALTH CARE DELIVERY; HUMAN; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; MALE; MALIGNANT LENTIGO; MELANOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SOCIAL STATUS; SOCIOECONOMICS; ULCER;

BRAZIL; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS; SOCIAL CLASS; SURVIVAL RATE;

EID: 84877011939     PISSN: 09608931     EISSN: 14735636     Source Type: Journal    
DOI: 10.1097/CMR.0b013e32835e76f8     Document Type: Article

References (32)

1. Miller AJ, Mihm MC Jr. Melanoma. N Engl J Med 2006; 355:51-65.
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007; 57:43-66.
3. MacKie RM, Hauschil A, Eggermont MM. Epidemiology of cutaneous melanoma. Ann Oncol 2009; 20 (Suppl 6):v1-v7.
4. Pe rez-Gomez P, Aragone s N, Gustavsson P, Lope V, Lo pez-Abente G, Pollan M. Socio-economic class, rurality and risk of cutaneous melanoma by site and gender in Sweden. BMC Public Health 2008; 8:33.
5. Shack L, Jordan C, Thomson CS, Mark V, Moller H. Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England. BMC Cancer 2008; 8:271.
6. Dalstra JAA, Knust AE, Borrell C, Breeze E, Cambois E, Costa G, et al. Socioeconomic differences in the prevalence of common chronic diseases: an overview of eight European countries. Int J Epidemiol 2005; 34: 316-326.
7. Beswick S, Affeck P, Elliott F, Gerry E, Boon A, Bale L, et al. Environmental risk factors for relapse of melanoma. Eur J Cancer 2008; 44:1717-1725.
8. Birch-Johansen F, Hvilsom G, Kjaer T, Storm H. Social inequality and incidence of and survival from malignant melanoma in a population-based study in Denmark, 1994-2003. Eur J Cancer 2008; 44:2043-2049.
9. Jeffreys M, Sarfati D, Stefanovic V, Tobias M, Lewis C, Pearce N, et al. Socioeconomic inequalities in cancer survival in New Zealand: the role of extent of disease at diagnosis. Cancer Epidemiol Biomarkers Prev 2009; 18:915-921.
10. Mandala M, Imberti GL, Piazzalunga D, Belfiglio M, Lucisano G, Labianca R, et al. Association of socioeconomic status with Breslow thickness and disease-free and overall survival in stage I-II primary cutaneous melanoma. Mayo Clin Proc 2011; 86:113-119.
11. Eide MJ, Weinstock MA, Clark MA. Demographic and socioeconomic predictors of melanoma prognosis in the United States. J Health Care Poor Underserved 2009; 20:227-245.
12. Liberatos P, Link BG, Kelsey JL. The measurement of social class in epidemiology. Epidemiol Rev 1988; 10:87-121.
13. National Cancer Institute of Brazil (INCA) Estimate 2010-Cancer Incidence in Brazil. Rio de Janeiro, 2009.
14. Balch CM, Gershenwald JE, Soong S-J, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27:6199-6206.
15. Livestro DP, Muzikansky A, Kaine EM, Flotte TJ, Sober AJ, Mihm MC, et al. Biology of desmoplastic melanoma: a case-control comparision with other melanomas. J Clin Oncol 2005; 23:6739-6746.
16. Clegg LX, Reichman ME, Miller BA, Hankey BF, Singh GK, Lin YD, et al. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: national longitudinal mortality study. Cancer Causes Control 2009; 20:417-435.
17. Brazilian Institute of Geography and Statistics (IBGE), 2000 Demographic Census-Education: Results of the Sample. Available at http://www.ibge.gov.br/ home/estatistica/populacao/censo2000/educacao/tabela-brasil.shtm [Accessed 26 June 2009].
18. Rachet B, Quinn MJ, Cooper N, Coleman MP. Survival of melanoma of the skin in England and Wales up to 2001. Br J Cancer 2008; 99:S47-S49.
19. Brazilian Institute of Geography and Statistics (IBGE), Synthesis of Social Indicators, 2006.
20. Lipsker D, Engel F, Cribier B, Velten M, Hedelin G. Trends in melanoma epidemiology suggest three different types of melanoma. Br J Dermatol 2007; 157:338-343.
21. Szklo A, Almeida LM, Figueiredo V, Lozana JA, Mendonc a GAS, Moura L, et al. Behaviors related to sunlight exposure versus protection in a random population sample from 15 Brazilian State capitals and the Federal District, 2002-2003. Cad Saude Publica 2007; 23:823-834.
22. Belloni-Fontini A, Piaserico S, Tonin E, Alaibac M. Melanoma and immunosupression. Dermatology 2009; 218:88.
23. Zell JA, Cinar P, Obasher M, Ziogas A, Meyskens FL, Anton-Cuver H. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. J Clin Oncol 2008; 26:66-75.
24. Mishima Y. Melanocytic and nevocytic malignant melanomas. Cancer 1967; 20:632-649.
25. Whiteman DC, Watt P, Purdie DM, Hughes MC, Hayward NK, Green AC. Melanocytic nevi, solar keratosis, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst 2003; 95:806-812.
26. Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med 2005; 353:2135-2147.
27. Fecher LA, Cummings SD, Keefe MJ, Alani RM. Toward a molecular classification of melanoma. J Clin Oncol 2007; 25:1606-1620.
28. Saldanha G, Potter L, DaForno P, Pringle JH. Cutaneous melanoma subtypes show different BRAF and NRAS mutation frequencies. Clin Cancer Res 2006; 12:4499-4505.
29. Anderson WF, Pfeiffer RM, Tucker MA, Rosenberg PS. Divergent cancer pathways for early-onset and late-onset cutaneous malignant melanoma. Cancer 2009; 115:4176-4185.
30. Lachiewicz AM, Berwick M,Wiggins CL, Thomas NE. Epidemiologic support for melanoma heterogeneity using the surveillance, epidemiology, and end results program. J Invest Dermatol 2008; 128:243-245.
31. Berwick M, Armstrong BK, Ben-Porat L, Fine J, Kricker A, Eberle C, et al. Sun exposure and mortality from melanoma. J Natl Cancer Inst 2005; 97:195-199.
32. Rosso S, Sera F, Segnan N, Zanetti R. Sun exposure prior to diagnosis is associated with improved survival in melanoma patients: results from a long-term follow-up study of Italian patients. Eur J Cancer 2008; 44:1275-1281.